Parenchyma-Preserving Hepatectomy in Perihilar Cholangiocarcinoma: A Chance for Critical Patients?
- PMID: 38584859
- PMCID: PMC10995988
- DOI: 10.1159/000537884
Parenchyma-Preserving Hepatectomy in Perihilar Cholangiocarcinoma: A Chance for Critical Patients?
Abstract
Introduction: Surgery for perihilar cholangiocarcinoma (pCCA) is associated with high rates of postoperative morbidity and mortality. Extended liver resection (EXT) increases R0 resection rate and survival; however, patients with high perioperative risk are not suitable for extended resection. This study aimed to compare overall survival and surgical morbidity in patients with extended liver resection and parenchyma-preserving hepatectomy (PPH).
Methods: Between January 2010 and November 2020, 113 consecutive patients with pCCA underwent surgery at our institution. Eighty-two patients were resected in curative intent. Sixty-four patients received extended liver resection, and 18 patients PPH. Outcomes of resections were evaluated.
Results: There was no significant difference in overall survival in patients with PPH compared to extended liver resection (log-rank p = 0.286). Patients with PPH experienced lower rates of postoperative morbidity and mortality. There was no case of in-house mortality in PPH-resected patients compared to 10 cases (16%) in patients that received EXT (p = 0.073).
Conclusion: PPH shows similar overall survival with lower rates of postoperative morbidity and mortality. Our findings support the role of a PPH, in selected patients with pCCA, that are not suitable for extended resection due to increased perioperative risk.
Keywords: Klatskin tumour; Parenchyma-preserving hepatectomy; Perihilar cholangiocarcinoma.
© 2024 S. Karger AG, Basel.
Conflict of interest statement
The authors have no conflicts of interest to declare.
Similar articles
-
Parenchyma-preserving hepatectomy in the surgical treatment of hilar cholangiocarcinoma.J Am Coll Surg. 1999 Dec;189(6):575-83. doi: 10.1016/s1072-7515(99)00219-7. J Am Coll Surg. 1999. PMID: 10589594
-
Surgical treatment of hilar cholangiocarcinoma in the new era: the Asan experience.J Hepatobiliary Pancreat Sci. 2010 Jul;17(4):476-89. doi: 10.1007/s00534-009-0204-5. Epub 2009 Oct 23. J Hepatobiliary Pancreat Sci. 2010. PMID: 19851704
-
[Hepatectomy (parenchyma-preserving) for hilar cholangiocarcinoma].Nihon Geka Gakkai Zasshi. 2000 May;101(5):413-7. Nihon Geka Gakkai Zasshi. 2000. PMID: 10884990 Japanese.
-
Robotic hepatectomy and biliary reconstruction for perihilar cholangiocarcinoma: a pioneer western case series.Updates Surg. 2021 Jun;73(3):999-1006. doi: 10.1007/s13304-021-01041-3. Epub 2021 Apr 16. Updates Surg. 2021. PMID: 33861401 Free PMC article. Review.
-
Can the Limits of Liver Transplantation Be Expanded in Perihilar Cholangiocarcinoma?J Gastrointest Cancer. 2022 Dec;53(4):1104-1112. doi: 10.1007/s12029-021-00735-6. Epub 2021 Nov 5. J Gastrointest Cancer. 2022. PMID: 34738188 Review.
Cited by
-
Influence of Perineural (Pn), Lymphangio (L) and Vascular (V) Invasion on Survival after Resection of Perihilar Cholangiocarcinoma.Cancers (Basel). 2024 Oct 12;16(20):3463. doi: 10.3390/cancers16203463. Cancers (Basel). 2024. PMID: 39456557 Free PMC article.
References
-
- Hartog H, Ijzermans JNM, van Gulik TM, Groot Koerkamp B. Resection of perihilar cholangiocarcinoma. Surg Clin North Am. 2016;96(2):247–67. - PubMed
-
- Ito F, Cho CS, Rikkers LF, Weber SM. Hilar cholangiocarcinoma: current management. Ann Surg. 2009;250(2):210–8. - PubMed
-
- van Keulen AM, Buettner S, Erdmann JI, Pratschke J, Ratti F, Jarnagin WR, et al. . Multivariable prediction model for both 90-day mortality and long-term survival for individual patients with perihilar cholangiocarcinoma: does the predicted survival justify the surgical risk? Br J Surg. 2023;110(5):599–605. - PMC - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources